Invention Grant
- Patent Title: EGFL6 specific monoclonal antibodies and methods of their use
-
Application No.: US17096280Application Date: 2020-11-12
-
Publication No.: US12152071B2Publication Date: 2024-11-26
- Inventor: Ningyan Zhang , Zhiqiang An , Anil K. Sood
- Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- Main IPC: C07K16/22
- IPC: C07K16/22 ; A61K9/00 ; A61K39/00 ; A61P35/00 ; C12N15/113 ; G01N33/574
Abstract:
Isolated or recombinant anti-EGFL6 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.
Public/Granted literature
- US20210130450A1 EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE Public/Granted day:2021-05-06
Information query
